DACT1 and breast carcinoma: Next, increased expression of Dact1 is known to inhibit proliferation of breast cancer cells through inhibition of Wnt/β-catenin signaling [26], while increased expression of Rgs2 is known to suppress growth of MCF7 and HEK293T breast carcinoma cells [27].